Back to search
Premature With Dysplasia Bronchopulmonary
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Premature With Dysplasia Bronchopulmonary trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Premature With Dysplasia Bronchopulmonary trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Around 50% of infants born extremely preterm develop a chronic lung disease known as bronchopulmonary dysplasia of which some infants will also develop pulmonar…
The goal of this study is to learn how a pregnant person's body processes caffeine and how much caffeine crosses the placenta to the baby. A small dose of caffe…
The researchers have worked to create consensus recommendations among national efforts to help with the transition and coordination of care for preterm infants…
The purpose of the study is to learn how safe montelukast may be in premature infants at significant risk for Bronchopulmonary Dysplasia (BPD) and to determine…
The purpose of this study is to evaluate the safety and explore the PK/PD of L-CIT supplementation in preterm infants to prevent the development of inflammatory…
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children…
Retinal vascularization in humans develops between the 16th and 36th weeks of amenorrhea, in a centrifugal pattern starting from the optic disc. In the case of…
Retinal vascularization in humans develops between the 16th and 36th week of amenorrhea, centrifugally from the papilla. In case of premature birth, the immatur…